A renewable source of donor cells for repetitive monitoring of T- and B-cell alloreactivity

American Journal of Transplantation

Volumn 5, Issue 1, 2005, Pages 76-86

  Zand, Martin S ^a   Bose, Anirban ^a   Vo, Thuong ^a   Coppage, Myra ^a   Pellegrin, Tina ^a   Arend, Lois ^a   Eun Hyung Lee, F ^a   Bozorgzadeh, Adel ^a   Leong, Nufatt ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Alloreactivity; CD40 ligand; Crossmatch; ELISPOT; Immune monitoring

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOIMMUNITY; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; FREEZING; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE CULTURE; ORGAN DONOR; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD3; ANTIGENS, CD80; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL LINE; CELL SEPARATION; CELL TRANSPLANTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENOTYPE; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; INTERFERON TYPE II; KIDNEY TRANSPLANTATION; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PHENOTYPE; RECEPTORS, FC; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES; TIME FACTORS; TISSUE DONORS;

EID: 11844268090     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2003.00637.x     Document Type: Article

References (52)

1. Thomson AW, Mazariegos GV, Reyes J et al. Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation 2001; 72(8 Suppl): S13-22.
2. Hricik DE, Heeger PS. Minimization of immunosuppression in kidney transplantation. The need for immune monitoring. Transplantation 2001; 72(8 Suppl): S32-35.
3. Heeger PS, Hricik D. Immune monitoring in kidney transplant recipients revisited. J Am Soc Nephrol 2002; 13: 288-290.
4. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267-2275.
5. VanBuskirk A, Wakely E, Sirak J, Orosz CG. Patterns of allosensitization in allograft recipients: Long term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive DTH. Transplantation 1998; 65: 1115-1123.
6. Mathew JM, Blomberg B, Fuller L et al. A novel micro-cell-mediated lympholytic assay for the evaluation of regulatory cells in human alloreactive CTL responses. J Immunol Methods 2003; 272: 67-80.
7. Jordan SC, Vo A, Bunnapradist S et al. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 2003; 76: 631-636.
8. Pelletier RP, Hennessy PK, Adams PW, Orosz CG. High incidence of donor-reactive delayed-type hypers ensitivity reactivity in transplant patients. Am J Transplant 2002; 2: 926-933.
9. Pelletier RP, Hennessy PK, Adams PW, VanBuskirk AM, Ferguson RM, Orosz CG. Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant 2002; 2: 134-141.
10. Takeda A, Uchida K, Haba T et al. Acute humoral rejection of kidney allografts in patients with a positive flow cytometry crossmatch (FCXM). Clin Transplant 2000; 14(Suppl 3): 15-20.
11. Bray RA, Lebeck LK, Gebel HM. The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities. Transplantation 1989; 48: 834-840.
12. Pelletier RP, Orosz CG, Adams PW et al. Clinical and economic impact of flow cytometry crossmatching in primary cadaveric kidney and simultaneous pancreas-kidney transplant recipients. Transplantation 1997; 63: 1639-1645.
13. Tilney NL, Whitley WD, Tullius SG et al. Serial analysis of cytokines, adhesion molecule expression, and humoral responses during development of chronic kidney allograft rejection in a new rat model. Transplant Proc 1993; 25(1 Pt 2): 861-862.
14. O'Rourke RW, Osorio RW, Freise CE et al. Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants. Clin Transplant 2000; 14: 167-173.
15. Abe M, Kawai T, Futatsuyama K et al. Postoperative production of anti-donor antibody and chronic rejection in renal transplantation. Transplantation 1997; 63: 1616-1619.
16. Abe M, Sannomiya A, Koike T et al. Postoperative production of anti-donor antibody and early graft loss due to vascular rejection in renal transplantation. Transplant Proc 1998; 30: 2963.
17. Scornik JC, Bray RA, Pollack MS et al. Multicenter evaluation of the flow cytometry T-cell crossmatch: Results from the American Society of Histocompatibility and Immunogenetics-College of American Pathologists proficiency testing program. Transplantation 1997; 63: 1440-1445.
18. Ghasemian SR, Light JA, Currier CB et al. The significance of the IgG anti-B-cell crossmatch on renal transplant outcome. Clin Transplant 1997; 11 (5 Pt 2): 485-487.
19. Vaidya S, Cooper TY, Stewart D, Gugliuzza K, Daller J, Bray RA. Pronase improves detection of HLA antibodies in flow crossmatches. Transplant Proc 2001; 33: 473-474.
20. Kerman RH, Orosz CG, Lorber MI. Clinical relevance of anti-HLA antibodies pre and post transplant. Am J Med Sci 1997; 313: 275-278.
21. Rebibou JM, Carvalho Bittencourt M, Saint-Hillier Y et al. T-cell flow-cytometry cross-match: Influence in renal transplantation. Transplant Proc 1998; 30: 2800-2801.
22. Smith JD, Danskine AJ, Laylor RM, Rose ML, Yacoub MH. The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. Transpl Immunol 1993; 1: 60-65.
23. Tambur AR, Bray RA, Takemoto SK et al. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation 2000; 70: 1055-1059.
24. Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574-582.
25. Barr ML, Baker CJ, Schenkel FA et al. Prophylactic photopheresis and chronic rejection: Effects on graft intimal hyperplasia in cardiac transplantation. Clin Transplant 2000; 14: 162-166.
26. Matesic D, Lehmann PV, Heeger PS. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 1998; 65: 906-914.
27. Orosz CG, Bickerstaff AA, Adams P, Hennessey P, Pelletier RP. Evidence that a similar range of alloimmune responses can develop in murine and human allograft recipients. Transpl Immunol 2002; 9: 143-147.
28. Schultze JL, Michalak S, Seamon MJ et al. CD40-activated human B cells: An alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest 1997; 100: 2757-2765.
29. Bidwell J. Advances in DNA-based HLA typing methods. Immunol Today 1994; 15: 303-307.
30. Bunce M. Comprehensive DNA typing for HLA-A,B,C,DRB3,4,5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCD-SSP). Tissue Antigens 1995; 46: 213-221.
31. Kao K, Scornik JC, Small S. Enzyme-linked immunoassay for anti-HLA antibodies - An alternative to panel studies by lymphocytotoxicity. Transplantation 1993; 55: 192-196.
32. Buscaroli A, De Sanctis LB, Iannelli S et al. Application of Prastat ELISA in the determination of anti-HLA specificity for immunized patients awaiting kidney transplant: Five years' experience. Transpl Int 2000; 13(Suppl 1): S99-105.
33. Pelletier RP, Adams PW, Hennessy PK, Orosz CG. Comparison of crossmatch results obtained by ELISA, flow cytometry, and conventional methodologies. Hum Immunol 1999; 60: 855-861.
34. Wells AD, Gudmundsdottir H, Turka LA. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 1997; 100: 3173-3183.
35. Takakura K, Kiuchi T, Kasahara M et al. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation. Clin Transplant 2001; 15: 309-316.
36. Hamrick CW, Lebeck LK. Flow cytometric T and B cell crossmatching. In: Hahn AB, Land GA, Strothman R, eds. ASHI laboratory manual, 4th Ed. Philadelphia: American Society for Histocompatibility and Immunogenetics, 2000: p. VI.B.41-45.
37. Hagiwara E, Abbasi F, Mor G, Ishigatsubo Y, Klinman DM. Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-alpha in human peripheral blood. Cytokine 1995; 7: 815-822.
38. Kreher CR, Dittrich MT, Guerkov R, Boehm BO, Tary-Lehmann M. CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J Immunol Methods 2003; 278: 79-93.
39. Truman JP, Ericson ML, Choqueux-Seebold CJ, Charron DJ, Mooney NA. Lymphocyte programmed cell death is mediated via HLA class II DR. Int Immunol 1994; 6: 887-896.
40. Yokochi T, Inoue Y, Iwata H, Miyadai T, Kimura Y. Differential expression of the major histocompatibility antigen complex (MHC) on a series of Burkitt's lymphoma lines. Microbiol Immunol 1987; 31: 1209-1215.
41. van Lochern EG, Bakker A, Snijder S, Aarts M, de Gast GC, Goulmy E. Epstein-Barr virus infection abrogates the stimulatory capacity of B cells to a major histocompatibility complex class-II-restricted proliferative T-cell clone. Hum Immunol 1995; 42: 137-144.
42. Manczak M, Dubis J, Kosc A et al. A new lymphoblastoid cell line defective in class II HLA expression. Arch Immunol Ther Exp (Warsz) 1996; 44: 171-178.
43. Contreras-Brodin BA, Anvret M, Imreh S, Altiok E, Klein G, Masucci MG. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: Studies with somatic cell hybrids. J Gen Virol 1991; 72(Pt 12): 3025-3033.
44. Gebel HM, Harris SB, Zibari G, Bray RA. Conundrums with Flow-PRA trade mark beads. Clin Transplant 2002; 16(Suppl 7): 24-29.
45. Pierquin A, Masson D, Toupance O et al. False-negative results in anti-HLA antibody detection by Sangstat ELISA: Complement dependent cytotoxicity is not yet obsolete. Transplantation 1996; 62: 1533-1534.
46. Worthington JE, Robson AJ, Sheldon S, Langton A, Martin S. A comparison of enzyme-linked immunoabsorbent assays and flow cytometry techniques for the detection of HLA specific antibodies. Hum Immunol 2001; 62: 1178-1184.
47. Rodriguez PC, Arroyave IH, Mejia G, Garcia LF. Detection of alloantibodies against non-HLA antigens in kidney transplantation by flow cytometry. Clin Transplant 2000; 14: 472-478.
48. Honjo T, Obata M, Yamawaki-Katoaka Y et al. Cloning and complete nucleotide sequence of mouse immunoglobulin gamma 1 chain gene. Cell 1979; 18: 559-568.
49. Matsuuchi L, Gold MR. New views of BCR structure and organization. Curr Opin Immunol 2001; 13: 270-277.
50. Vaidya S, Cooper TY, Avandsalehi J et al. Improved flow cytometric detection of HLA alloantibodies using pronase: Potential implications in renal transplantation. Transplantation 2001; 71: 422-428.
51. Lobashevsky AL, Senkbeil RW, Shoaf J et al. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation. Clin Transplant 2000; 14: 533-542.
52. Le Bas-Bernardet S, Hourmant M, Valentin N et al. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation 2003; 75: 477-482.